Atlas Trials

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan

Clinical trial NCT06684314 · RECRUITING

Trial details

NCT number
NCT06684314
Sponsor
Sanofi
Status
RECRUITING
Study type
OBSERVATIONAL
Hemophilia A
Start date
2024-11-11
Primary completion
2031-08-28
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.